Mark Michels
Overview
Explore the profile of Mark Michels including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
1710
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eichenbaum D, Freeman W, Chang M, Brooks L, Chaudhry N, Dadgostar H, et al.
Ophthalmol Retina
. 2024 Aug;
9(2):127-143.
PMID: 39154860
Purpose: The Port Delivery System with ranibizumab (PDS) is approved in the United States for neovascular age-related macular degeneration. The United States Prescribing Information has a Boxed Warning for endophthalmitis...
2.
Loewenstein A, Ferencz J, Lang Y, Yeshurun I, Pollack A, Siegal R, et al.
Retina
. 2010 Mar;
30(7):1058-64.
PMID: 20234332
Purpose: The primary purpose of this study was to evaluate the ability of a home device preferential hyperacuity perimeter to discriminate between patients with choroidal neovascularization (CNV) and intermediate age-related...
3.
Brown D, Michels M, Kaiser P, Heier J, Sy J, Ianchulev T
Ophthalmology
. 2009 Jan;
116(1):57-65.e5.
PMID: 19118696
Objective: The 2-year, phase III trial designated Anti-vascular endothelial growth factor (VEGF) Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (ANCHOR) compared ranibizumab with...
4.
Brown D, Kaiser P, Michels M, Soubrane G, Heier J, Kim R, et al.
N Engl J Med
. 2006 Oct;
355(14):1432-44.
PMID: 17021319
Background: We compared ranibizumab--a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A--with photodynamic therapy with verteporfin in the treatment of predominantly classic...
5.
Zaldivar R, Michels M, Grant K, Clark W, Grossniklaus H
Retina
. 2004 Apr;
24(2):226-30.
PMID: 15097882
Purpose: To evaluate the clinical and pathologic findings in two patients with prior breast carcinoma who underwent diagnostic vitrectomy for vitreous opacities and preretinal membrane. Methods: The clinical histories and...